ORAL COMBINATION DRUG FORMULATION COMPRISING A NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND A COMPLEMENTARY LOW DOSE OF TRANEXAMIC ACID FOR THE TREATMENT OF MENSTRUAL PAIN ACCOMPANIED WITH EXCESSIVE MENSTRUAL BLOOD LOSS, 16/292,473 (U.S. Pat. App.)

Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing, 10/36,732 (U.S. Pat. App.)

ANTI-PROLIFERATIVE AND ANTI-INFLAMMATORY AGENT COMBINATION FOR TREATMENT OF VASCULAR DISORDERS WITH AN IMPLANTABLE MEDICAL DEVICE, 11/90,507 (U.S. Pat. App.)

5-[(3,3,3-TRIFLUORO-2-HYDROXY-1-ARYLPROPYL)AMINO]-1H-QUINOLIN-2-ONES, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS, 15/80,187 (U.S. Pat. App.)

COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN AN ELASTASE INHIBITOR COMPOUND OF THE N-ACYLAMINOAMIDE FAMILY AND AT LEAST ONE ANTI-INFLAMMATORY COMPOUND, 10/179,955 (U.S. Pat. App.)

AVIR THROUGH BIO-ACTIVE PARTICLES OF COPPER MAY REDUCE THE RISK OF VIRAL AND BACTERIAL INFECTIONS. COPPER IS KNOWN TO HELP MAINTAIN A HEALTHY CIRCULATORY SYSTEM AND IS KNOWN TO ACT AS AN ANTIVIRAL, ANTIBACTERIAL, AND ANTI-INFLAMMATORY. AVIR MAY BE USEFUL FOR TREATING OR PREVENTING A WIDE VARIETY OF VIRAL OR BACTERIAL DISEASES. IT CONTAINS COPPER PARTICLES IN THE CASING OF LIPIDS (FATS), AND OTHER SUBSTANCES THAT HELP WITH ABSORPTION AND CELLULAR PENETRATION. THESE PARTICLES ARE INSOLUBLE, AND THEIR SIZE IS TINY -- 30-40 NANOMETERS (FOR COMPARISON, DIAMETER OF CORONAVIRUS PARTICLES ARE APPROXIMATELY 125 NANOMETERS)., 90290536 (Trademark)

NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS, 17/132,238 (U.S. Pat. App.)

NOVEL MONOCLONAL ANTIBODY HAVING ANTI-INFLAMMATORY ACTION, 17/58,143 (U.S. Pat. App.)

2-SPIRO(2'-SPIROCYCLOALKYL)CYCLOPROPYL CEPHALOSPORIN SULFONES AS ANTIINFLAMMATORY AND ANTIDEGENERATIVE AGENTS, 08/162,478 (U.S. Pat. App.)

D-ENANTIOMERIC PEPTIDES FOR ANTI-INFLAMMATORY TREATMENT OF AMYOTROPIC LATERAL SCLEROSIS (ALS) AND OTHER DISEASES DRIVEN BY NEURO-INFLAMMATION, 17/52,258 (U.S. Pat. App.)

GLUCOCORTIOCOID-SELECTIVE ANTIINFLAMMATORY AGENTS, 09/247,831 (U.S. Pat. App.)

DELIVERY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS THROUGH AN INHALATION ROUTE, 10/766,279 (U.S. Pat. App.)

Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds, 10/921,965 (U.S. Pat. App.)

PEPTIDYL 4-AMINO-2,2-DIFLUORO-3-OXO-1,6-HEXANEDIOIC ACID DERIVATIVES AS ANTIINFLAMMATORY AGENTS, 08/373,278 (U.S. Pat. App.)

N-ACYL SUBSTITUTED PHENYL PIPERIDINES AS BRONCHODILATORS AND ANTIINFLAMMATORY AGENTS, 08/230,271 (U.S. Pat. App.)